Levonorgestrel-Releasing Intrauterine System Alone as Primary Treatment in Young Women with Early Endometrial Cancer: Case Report
article
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This case report describes the successful primary treatment of early endometrial cancer in a young woman using a levonorgestrel-releasing intrauterine system.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (30)
- W1529862692 via openalex
- W1891126000 via openalex
- W1933506009 via openalex
- W1968400287 via openalex
- W1979945461 via openalex
- W1982471535 via openalex
- W1994296862 via openalex
- W2025504099 via openalex
- W2030538772 via openalex
- W2036395353 via openalex
- W2042858996 via openalex
- W2047111383 via openalex
- W2074859203 via openalex
- W2086713990 via openalex
- W2088185348 via openalex
- W2123725304 via openalex
- W2147907268 via openalex
- W2163130168 via openalex
- W2186218348 via openalex
- W2338305153 via openalex
- W2408762882 via openalex
- W2414522975 via openalex
- W2416463492 via openalex
- W2460305064 via openalex
- W4254007528 via openalex
- W4255462147 via openalex
- W4256605237 via openalex
- W6659813615 via openalex
- W6716364656 via openalex
- W7073660035 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK